annual EBITDA:
-$192.36M-$107.70M(-127.22%)Summary
- As of today (June 17, 2025), MLYS annual EBITDA is -$192.36 million, with the most recent change of -$107.70 million (-127.22%) on December 31, 2024.
- During the last 3 years, MLYS annual EBITDA has fallen by -$172.98 million (-892.52%).
- MLYS annual EBITDA is now -5709.73% below its all-time high of -$3.31 million, reached on December 1, 2020.
Performance
MLYS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$44.43M+$7.32M(+14.14%)Summary
- As of today (June 17, 2025), MLYS quarterly EBITDA is -$44.43 million, with the most recent change of +$7.32 million (+14.14%) on March 31, 2025.
- Over the past year, MLYS quarterly EBITDA has dropped by -$9.08 million (-25.68%).
- MLYS quarterly EBITDA is now -585.78% below its all-time high of -$6.48 million, reached on June 1, 2022.
Performance
MLYS quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$201.44M-$9.08M(-4.72%)Summary
- As of today (June 17, 2025), MLYS TTM EBITDA is -$201.44 million, with the most recent change of -$9.08 million (-4.72%) on March 31, 2025.
- Over the past year, MLYS TTM EBITDA has dropped by -$96.36 million (-91.71%).
- MLYS TTM EBITDA is now -2743.96% below its all-time high of -$7.08 million, reached on December 1, 2021.
Performance
MLYS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MLYS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -127.2% | -25.7% | -91.7% |
| 3 y3 years | -892.5% | -487.0% | -1274.8% |
| 5 y5 years | -5709.7% | -527.3% | -2744.0% |
MLYS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -892.5% | at low | -585.8% | +26.1% | -853.3% | at low |
| 5 y | 5-year | -5709.7% | at low | -585.8% | +26.1% | -2744.0% | at low |
| alltime | all time | -5709.7% | at low | -585.8% | +26.1% | -2744.0% | at low |
MLYS EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$44.43M(-14.1%) | -$201.44M(+4.7%) |
| Dec 2024 | -$192.36M(+127.2%) | -$51.75M(-13.9%) | -$192.36M(+14.3%) |
| Sep 2024 | - | -$60.09M(+33.1%) | -$168.32M(+25.1%) |
| Jun 2024 | - | -$45.16M(+27.7%) | -$134.50M(+28.0%) |
| Mar 2024 | - | -$35.35M(+27.6%) | -$105.07M(+24.1%) |
| Dec 2023 | -$84.66M | -$27.71M(+5.5%) | -$84.66M(+26.4%) |
| Sep 2023 | - | -$26.27M(+67.0%) | -$66.95M(+39.2%) |
| Jun 2023 | - | -$15.73M(+5.3%) | -$48.10M(+23.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$14.94M(+49.3%) | -$38.85M(+23.4%) |
| Dec 2022 | -$31.48M(+62.4%) | -$10.01M(+34.8%) | -$31.48M(+10.2%) |
| Sep 2022 | - | -$7.42M(+14.6%) | -$28.55M(+35.1%) |
| Jun 2022 | - | -$6.48M(-14.4%) | -$21.13M(+44.2%) |
| Mar 2022 | - | -$7.57M(+6.9%) | -$14.65M(+106.9%) |
| Dec 2021 | -$19.38M(+485.4%) | - | - |
| Dec 2021 | - | -$7.08M | -$7.08M |
| Dec 2020 | -$3.31M | - | - |
FAQ
- What is Mineralys Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual EBITDA year-on-year change?
- What is Mineralys Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly EBITDA year-on-year change?
- What is Mineralys Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Mineralys Therapeutics?
- What is Mineralys Therapeutics TTM EBITDA year-on-year change?
What is Mineralys Therapeutics annual EBITDA?
The current annual EBITDA of MLYS is -$192.36M
What is the all time high annual EBITDA for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual EBITDA is -$3.31M
What is Mineralys Therapeutics annual EBITDA year-on-year change?
Over the past year, MLYS annual EBITDA has changed by -$107.70M (-127.22%)
What is Mineralys Therapeutics quarterly EBITDA?
The current quarterly EBITDA of MLYS is -$44.43M
What is the all time high quarterly EBITDA for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly EBITDA is -$6.48M
What is Mineralys Therapeutics quarterly EBITDA year-on-year change?
Over the past year, MLYS quarterly EBITDA has changed by -$9.08M (-25.68%)
What is Mineralys Therapeutics TTM EBITDA?
The current TTM EBITDA of MLYS is -$201.44M
What is the all time high TTM EBITDA for Mineralys Therapeutics?
Mineralys Therapeutics all-time high TTM EBITDA is -$7.08M
What is Mineralys Therapeutics TTM EBITDA year-on-year change?
Over the past year, MLYS TTM EBITDA has changed by -$96.36M (-91.71%)